Acupet Vet Ltd SC686650 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true SC686650 2024-04-01 2025-03-31 SC686650 2025-03-31 SC686650 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 SC686650 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2025-03-31 SC686650 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2025-03-31 SC686650 core:FinanceLeases core:CurrentFinancialInstruments 2025-03-31 SC686650 core:FinanceLeases core:Non-currentFinancialInstruments 2025-03-31 SC686650 core:CurrentFinancialInstruments 2025-03-31 SC686650 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 SC686650 core:Non-currentFinancialInstruments 2025-03-31 SC686650 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 SC686650 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 SC686650 core:FurnitureFittingsToolsEquipment 2025-03-31 SC686650 core:LandBuildings 2025-03-31 SC686650 core:MotorVehicles 2025-03-31 SC686650 bus:SmallEntities 2024-04-01 2025-03-31 SC686650 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 SC686650 bus:FilletedAccounts 2024-04-01 2025-03-31 SC686650 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 SC686650 bus:RegisteredOffice 2024-04-01 2025-03-31 SC686650 bus:Director1 2024-04-01 2025-03-31 SC686650 bus:Director2 2024-04-01 2025-03-31 SC686650 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC686650 core:PatentsTrademarksLicencesConcessionsSimilar 2024-04-01 2025-03-31 SC686650 core:FurnitureFittings 2024-04-01 2025-03-31 SC686650 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 SC686650 core:LandBuildings 2024-04-01 2025-03-31 SC686650 core:LeaseholdImprovements 2024-04-01 2025-03-31 SC686650 core:MotorVehicles 2024-04-01 2025-03-31 SC686650 core:OfficeEquipment 2024-04-01 2025-03-31 SC686650 core:PlantMachinery 2024-04-01 2025-03-31 SC686650 core:KeyManagementPersonnel 2024-04-01 2025-03-31 SC686650 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-04-01 2025-03-31 SC686650 countries:EnglandWales 2024-04-01 2025-03-31 SC686650 2024-03-31 SC686650 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 SC686650 core:FurnitureFittingsToolsEquipment 2024-03-31 SC686650 core:LandBuildings 2024-03-31 SC686650 core:MotorVehicles 2024-03-31 SC686650 2023-04-01 2024-03-31 SC686650 2024-03-31 SC686650 core:AcceleratedTaxDepreciationDeferredTax 2024-03-31 SC686650 core:FinanceLeases core:CurrentFinancialInstruments 2024-03-31 SC686650 core:FinanceLeases core:Non-currentFinancialInstruments 2024-03-31 SC686650 core:CurrentFinancialInstruments 2024-03-31 SC686650 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 SC686650 core:Non-currentFinancialInstruments 2024-03-31 SC686650 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 SC686650 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 SC686650 core:FurnitureFittingsToolsEquipment 2024-03-31 SC686650 core:LandBuildings 2024-03-31 SC686650 core:MotorVehicles 2024-03-31 iso4217:GBP xbrli:pure

Registration number: SC686650

Prepared for the registrar

Acupet Vet Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2025

 

Acupet Vet Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

Acupet Vet Ltd

Company Information

Directors

D O Baranska

L J Baranski

Registered office

Bruach Mhor
Knockfarrel
Dingwall
Highlands
IV15 9TQ

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Acupet Vet Ltd

(Registration number: SC686650)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

1,020

1,530

Tangible assets

5

130,353

33,898

 

131,373

35,428

Current assets

 

Stocks

27,920

778

Debtors

6

5,050

7,965

Cash at bank and in hand

 

34,283

2,186

 

67,253

10,929

Creditors: Amounts falling due within one year

7

(153,243)

(6,891)

Net current (liabilities)/assets

 

(85,990)

4,038

Total assets less current liabilities

 

45,383

39,466

Creditors: Amounts falling due after more than one year

7

(102,488)

(29,228)

Deferred tax liabilities

8

6,720

(6,366)

Net (liabilities)/assets

 

(50,385)

3,872

Capital and reserves

 

Called up share capital

100

100

Retained earnings

(50,485)

3,772

Shareholders' (deficit)/funds

 

(50,385)

3,872

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 25 September 2025 and signed on its behalf by:
 


D O Baranska
Director


L J Baranski
Director

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Bruach Mhor
Knockfarrel
Dingwall
Highlands
IV15 9TQ

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tax

The tax expense for the period comprises and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold property

10% of cost

Plant and machinery

25% of written down value

Fixtures and fittings

10% of written down value

Office equipment

33% of cost

Motor vehicles

25% of written down value

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Website

33% over 3 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 8 (2024 - 1).

 

4

Intangible assets

Websites
 £

Total
£

Cost

At 1 April 2024

1,530

1,530

At 31 March 2025

1,530

1,530

Amortisation

Amortisation charge

510

510

At 31 March 2025

510

510

Carrying amount

At 31 March 2025

1,020

1,020

At 31 March 2024

1,530

1,530

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

5

Tangible assets

Leasehold improvements
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 April 2024

1,291

2,605

57,166

61,062

Additions

-

124,473

-

124,473

At 31 March 2025

1,291

127,078

57,166

185,535

Depreciation

At 1 April 2024

288

1,195

25,680

27,163

Charge for the year

129

20,018

7,872

28,019

At 31 March 2025

417

21,213

33,552

55,182

Carrying amount

At 31 March 2025

874

105,865

23,614

130,353

At 31 March 2024

1,003

1,409

31,486

33,898

 

6

Debtors

2025
£

2024
£

Trade debtors

1,261

2,017

Prepayments

3,789

5,948

5,050

7,965

 

7

Creditors

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

9

63,266

3,826

Trade creditors

 

24,427

-

Taxation and social security

 

19,289

924

Accruals and deferred income

 

5,791

2,051

Other creditors

 

40,470

90

 

153,243

6,891

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

9

102,488

29,228

 

Acupet Vet Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

8

Deferred tax

Deferred tax assets and liabilities

2025

Liability
£

Fixed asset timing differences

30,389

Short term timing differences

(40)

Losses and other deductions

(37,069)

(6,720)

2024

Liability
£

Fixed asset timing differences

6,366

6,366

 

9

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank borrowings

9,600

-

Finance lease liabilities

17,019

2,878

Other borrowings

36,647

948

63,266

3,826

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

29,600

-

Finance lease liabilities

72,888

29,228

102,488

29,228

 

10

Related party transactions

Key management personnel

Key management personnel are the directors of the company.

Summary of transactions with key management

As at the balance sheet date, the company owed the directors £36,647 (2024: £948). This amount is included in other borrowings. Interest is charged and there are no fixed repayment terms.